Rapid Tests Market Growth Outlook From $38.66 Billion In 2026 To $59.06 Billion By 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Rapid Tests Market Growth From $38.66 Billion In 2026 To $59.06 Billion By 2030 At A CAGR Of 11.2%
The rapid tests market size has experienced substantial expansion in recent years. This market is projected to grow from $34.67 billion in 2025 to $38.66 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.5%. The expansion witnessed during the historic period can be attributed to a heightened demand for swift disease identification, advancements in lateral flow assay technologies, increasing awareness about preventive healthcare, the development of healthcare infrastructure in emerging economies, and the rising prevalence of infectious diseases.
The market for rapid tests is projected to experience substantial expansion in the coming years. This market is projected to reach $59.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This anticipated growth throughout the forecast period stems from factors such as the incorporation of AI and IoT into rapid tests, increasing uptake of home healthcare options, the creation of multiplex testing kits, the broadening scope of personalized medicine, and governmental programs that back point-of-care diagnostic tools. Key trends anticipated during this period encompass the widening availability of point-of-care testing, the miniaturization of diagnostic instruments, swift screening for infectious diseases, diagnostic solutions designed for home use, and the development of economical testing alternatives.
Get A Free Sample Report With In-Depth Market Insights:
Rapid Tests Market Growth Momentum: What Factors Are Shaping Demand?
The increasing occurrence of infectious diseases is projected to fuel the expansion of the rapid tests market in the future. These diseases are ailments resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of transmission between individuals either directly or indirectly. The growing prevalence of infectious diseases stems from increased travel, which allows pathogens to quickly disseminate internationally. Rapid diagnostic tests aid in combating infectious diseases by facilitating swift and precise detection where care is provided, thereby permitting prompt treatment and patient isolation. These tests bolster public health strategies by minimizing diagnostic wait times, enhancing disease control, and curbing the transmission of infections. For example, in February 2024, the UK Health Security Agency, a government body based in the UK, reported that tuberculosis (a communicable bacterial infection mainly impacting the lungs) instances in England climbed to 4,850 in 2023, representing a 10.7% rise from 4,380 cases recorded in 2022. Consequently, the escalating incidence of infectious diseases is propelling the expansion of the rapid tests market.
Rapid Tests Market Segment Analysis: What Are The Core Market Categories?
The rapid tests market covered in this report is segmented –
1) By Product: Instruments, Consumables, Other Products
2) By Contaminants: Pathogens, Allergens
3) By Technology: Polymerase Chain Reaction (PCR)-Based, Immunoassay-Based, Chromatography-Based
4) By Application: Cardiology, Oncology, Pregnancy And Fertility, Toxicology, Glucose Monitoring, Infectious Disease, Other Applications
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End-Users
Subsegments:
1) By Instruments: Portable Analyzers, Benchtop Analyzers, Handheld Devices, Readers Or Scanners, Multiplex Analyzers
2) By Consumables: Test Strips, Test Cassettes Or Cartridges, Reagents, Sample Collection Devices, Control And Calibration Materials
3) By Other Products: Software And Data Management Systems, Accessories, Maintenance And Service Kits
Rapid Tests Market Trends Redefining Industry Growth
Major companies in the rapid tests market are focusing on developing technologically sophisticated solutions, such as advanced bioluminescence technology, to enable more rapid, sensitive, and precise pathogen detection. This advanced bioluminescence technology refers to the application of light-emitting biochemical reactions, typically involving luciferase enzymes and substrates, to identify the presence of microorganisms or biological markers. For example, in March 2025, Nelson Labs, a US-based testing services provider, launched a rapid sterility testing method. This new testing approach utilizes advanced bioluminescence technology to decrease the traditional 14-day incubation period to as little as six days. The system detects microbial adenosine triphosphate (ATP), an indicator of living organisms, by measuring the light produced during the bioluminescent reaction. It automates the identification of microbial contamination, improves accuracy, and ensures regulatory compliance, thereby allowing for faster, dependable product release without compromising safety.
Rapid Tests Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the rapid tests market are F Hoffmann La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens Healthineers, BioMerieux SA, Quidel Corporation, Bio Rad Laboratories Inc, PerkinElmer Inc, OraSure Technologies Inc, SEKISUI Diagnostics LLC, Trivitron Healthcare Pvt Ltd, Ellume Limited, Access Bio Inc, ACON Laboratories Inc, CTK Biotech Inc, iHealth Labs Inc, Wondfo USA Co Ltd, InBios International Inc, Lab Care Diagnostics India Pvt Ltd, Immunostics Inc, Aptitude Medical Systems Inc, Beijing Hotgen Biotech Co Ltd, CorDx Inc, Maxim Biomedical Inc, OSANG LLC
View The Full Rapid Tests Market Report:
Rapid Tests Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the rapid tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
